471 related articles for article (PubMed ID: 30462965)
1. [Progress in research of bacillus calmette-guerin vaccination and repeated vaccination].
You NN; Liu Q; Zhu LM; Lu W
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Nov; 39(11):1519-1523. PubMed ID: 30462965
[TBL] [Abstract][Full Text] [Related]
2. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
[TBL] [Abstract][Full Text] [Related]
4. Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK.
Mangtani P; Nguipdop-Djomo P; Keogh RH; Trinder L; Smith PG; Fine PE; Sterne J; Abubakar I; Vynnycky E; Watson J; Elliman D; Lipman M; Rodrigues LC
Health Technol Assess; 2017 Jul; 21(39):1-54. PubMed ID: 28738015
[TBL] [Abstract][Full Text] [Related]
5. Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland.
Sweeney E; Dahly D; Seddiq N; Corcoran G; Horgan M; Sadlier C
BMC Infect Dis; 2019 May; 19(1):397. PubMed ID: 31072396
[TBL] [Abstract][Full Text] [Related]
6. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis.
Abubakar I; Pimpin L; Ariti C; Beynon R; Mangtani P; Sterne JA; Fine PE; Smith PG; Lipman M; Elliman D; Watson JM; Drumright LN; Whiting PF; Vynnycky E; Rodrigues LC
Health Technol Assess; 2013 Sep; 17(37):1-372, v-vi. PubMed ID: 24021245
[TBL] [Abstract][Full Text] [Related]
7. [BCG vaccines for the prevention of tuberculosis in the world].
Hashimoto T
Kekkaku; 1997 Nov; 72(11):629-37. PubMed ID: 9423301
[TBL] [Abstract][Full Text] [Related]
8. Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis.
Xing Z; Charters TJ
Expert Rev Vaccines; 2007 Aug; 6(4):539-46. PubMed ID: 17669008
[TBL] [Abstract][Full Text] [Related]
9. BCG vaccine: WHO position paper, February 2018 - Recommendations.
World Health Organization
Vaccine; 2018 Jun; 36(24):3408-3410. PubMed ID: 29609965
[TBL] [Abstract][Full Text] [Related]
10. Tuberculosis vaccine: A journey from BCG to present.
Fatima S; Kumari A; Das G; Dwivedi VP
Life Sci; 2020 Jul; 252():117594. PubMed ID: 32305522
[TBL] [Abstract][Full Text] [Related]
11. Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial.
Nankabirwa V; Tumwine JK; Namugga O; Tylleskär T; Ndeezi G; Robberstad B; Netea MG; Sommerfelt H
Trials; 2017 Mar; 18(1):152. PubMed ID: 28359325
[TBL] [Abstract][Full Text] [Related]
12. The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?
Martín C
Eur Respir J; 2005 Jul; 26(1):162-7. PubMed ID: 15994403
[TBL] [Abstract][Full Text] [Related]
13. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
Fu H; Lin HH; Hallett TB; Arinaminpathy N
Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270
[TBL] [Abstract][Full Text] [Related]
14. Critical research concepts in tuberculosis vaccine development.
Delogu G; Manganelli R; Brennan MJ
Clin Microbiol Infect; 2014 May; 20 Suppl 5():59-65. PubMed ID: 24283256
[TBL] [Abstract][Full Text] [Related]
15. What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us?
Menzies D
Clin Infect Dis; 2000 Sep; 31 Suppl 3():S71-4. PubMed ID: 11010826
[TBL] [Abstract][Full Text] [Related]
16. Protection against tuberculosis by Bacillus Calmette-Guérin (BCG) vaccination: A historical perspective.
Setiabudiawan TP; Reurink RK; Hill PC; Netea MG; van Crevel R; Koeken VACM
Med; 2022 Jan; 3(1):6-24. PubMed ID: 35590145
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis: vaccines in the pipeline.
Ly LH; McMurray DN
Expert Rev Vaccines; 2008 Jul; 7(5):635-50. PubMed ID: 18564018
[TBL] [Abstract][Full Text] [Related]
18. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?
Moliva JI; Turner J; Torrelles JB
Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.
Colditz GA; Berkey CS; Mosteller F; Brewer TF; Wilson ME; Burdick E; Fineberg HV
Pediatrics; 1995 Jul; 96(1 Pt 1):29-35. PubMed ID: 7596718
[TBL] [Abstract][Full Text] [Related]
20. [A systematic review on the protective efficacy of BCG against children tuberculosis meningitis and millet tuberculosis].
Xiong CH; Liang XF; Wang HQ
Zhongguo Yi Miao He Mian Yi; 2009 Aug; 15(4):358-62. PubMed ID: 20077739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
